Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CRISPR Therapeutics AG

    NASDAQ: CRSP · Real-Time Price · USD
    59.97
    1.15 (1.96%)
    At close: Aug 15, 2025, 1:20 PM

    CRISPR Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 298.26M 389.48M 211.88M 923.03M
    Short-Term Investments
    		 1.61B 1.3B 1.6B 1.46B
    Long-Term Investments
    		 n/a 1.97M 53.13M 16.91M
    Other Long-Term Assets
    		 27.35M 13.57M 16.27M 22.2M
    Receivables
    		 25M 200M n/a 305K
    Inventory
    		 n/a n/a -11.2M n/a
    Other Current Assets
    		 8.31M 14.39M 37.71M n/a
    Total Current Assets
    		 1.94B 1.91B 1.85B 2.42B
    Property-Plant & Equipment
    		 277.55M 305.94M 320.56M 312.04M
    Goodwill & Intangibles
    		 n/a 16K 71K 125K
    Total Long-Term Assets
    		 304.9M 321.49M 390.03M 334.36M
    Total Assets
    		 2.24B 2.23B 2.24B 2.75B
    Account Payables
    		 14.71M 38.15M 27.43M 14.82M
    Deferred Revenue
    		 3.85M 4.11M 12.32M 1.01M
    Short-Term Debt
    		 17.29M 27.99M 15.84M 12.16M
    Other Current Liabilities
    		 51.94M 33.13M 42.62M 55.35M
    Total Current Liabilities
    		 87.78M 108.79M 121.11M 119.88M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 3.44M 958K 5.97M 7.34M
    Total Long-Term Liabilities
    		 222.17M 237.98M 246.47M 232.53M
    Total Liabilities
    		 309.95M 346.77M 367.58M 352.42M
    Total Debt
    		 223.69M 238.63M 244.02M 225.03M
    Common Stock
    		 2.7M 2.5M 2.44M 2.39M
    Retained Earnings
    		 -1.37B -999.7M -846.09M -195.91M
    Comprehensive Income
    		 1.84M 1.91M -15.65M -5.07M
    Shareholders Equity
    		 1.93B 1.88B 1.88B 2.4B
    Total Investments
    		 1.61B 1.31B 1.66B 1.46B

    Add to Watchlist